Loading...
Dernières publications
-
Luce Barbat Du Closel, Nathalie Bonello-Palot, Yann Pereon, Andoni Echaniz-Laguna, Jean Philippe Camdessanche, et al.. Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease. European Journal of Neurology, 2023, 30 (10), pp.3265-3276. ⟨10.1111/ene.15937⟩. ⟨hal-04254200⟩
-
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Leonard-Louis, Stéphane Ederhy, et al.. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discovery, 2023, 13 (5), pp.1100-1115. ⟨10.1158/2159-8290.CD-22-1180⟩. ⟨hal-04578810⟩
-
Corinna Preuße, Barbara Paesler, Christopher Nelke, Derya Cengiz, Thomas Müntefering, et al.. Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis. Acta Neuropathologica, 2022, 144 (2), pp.353-372. ⟨10.1007/s00401-022-02438-z⟩. ⟨hal-03830925⟩
-
Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-03832478⟩
-
Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-04002766⟩
-
Stéphane Ederhy, Perrine Devos, Bruno Pinna, Elisa Funck-Brentano, Baptiste Abbar, et al.. 8 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography imaging for the diagnosis of immune checkpoint inhibitors associated myocarditis. Archives of cardiovascular diseases, 2022, ⟨10.1016/j.acvd.2021.12.001⟩. ⟨hal-03561783⟩
-
Pierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, Matthieu Mahevas, Nicolas de Prost, et al.. Plasma exchange are not associated with better outcome in MDA5 rapidly-progressive interstitial lung disease. French Intensive Care Society International Congress 2022, 2022, paris, France. pp.54, ⟨10.1186/s13613-022-01016-6⟩. ⟨hal-03831253⟩
Chiffres clés
123
Publications avec texte intégral
Open Access
53 %
Mots clés
Acute Kidney Injury/epidemiology/etiology
Adeno-associated virus
Polymyositis
Amyotrophic lateral sclerosis
Cytokines
Amyotrophy
Sphingosine-1-phosphate
IMNM
Antibodies
Dependovirus/genetics/immunology
Adeno-associated vector
Anticorps anti-agalsidase
Inflammation
Biomarkers
Aged
Anémie hémolytique
Immune checkpoint inhibitors
Active
Adverse drug reactions
Case reports
Agalsidase
Idiopathic inflammatory myopathies
AAV
Prognosis
Muscle
Antisynthetase syndrome
Myopathy
Interstitial lung disease
Assisted communication devices
Anti-agalsidase antibodies
Machine learning
Arthritis
Male
Myositis
Dermatomyositis
Abnormal movement
Biomarqueurs
Acid-alpha-glucosidase
Lysosomal storage diseases
Pharmacology
Middle Aged
Anti-interleukin-6
Antiphospholipid syndrome
Adeno-associated virus vector
Anticorps spécifique des myosites
Female
Analyses multidimensionnelles
Aldosterone
Autoimmunity
Skeletal muscle
Adult
B-lymphocyte
Mass cytometry
Inflammatory myopathy
Autoimmune diseases
Autoantibody
Aldostérone
Anti-IgE IgG
Anti‐mitochondrial antibodies
Gene therapy
COVID-19
IBM
Systems biology
DM
Animals
Adolescence
Anti-drug antibodies
Outcome measures
AAV vectors
Fabry disease
Cancer
Anti-Mi2
Auto-antibodies
Data integration
AAV antibody
Biopsy
AAV vector
Myositis and muscle disease
Autoantibodies
Cardio-oncology
Antisynthétase
Auto-immunité
Humans
Inclusion body myositis
B cell homeostasis
AAV humoral immunity
Anti-MDA5 autoantibodies
Antisynthetase
Multidisciplinarity
Inborn errors of metabolism
Biomarker
Anti-synthetase syndrome
Bioelectrical impedance analysis
Auto‐antibodies
Myocarditis
Interferon
Deep immune profiling
Adjudication
Antibody responses
Immunotherapy